OMRIX BIOPHARMACEUTICALS
0455.883.073 · rovalta.com · 24/09/2026
ACTIVE
OMRIX BIOPHARMACEUTICALS
Financial year 2025 · Closed on 31/12/2025
Net result
32 k €
+146,9 %over 1 yearRevenue
107 M €
+6,5 %over 1 yearEquity
18,5 M €
+0,2 %over 1 yearWorkforce
1,0 ETP
-23,1 %over 1 yearOverview
Identity
Source · BCE/KBOOMRIX BIOPHARMACEUTICALS is a Public limited company incorporated in 1995. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 1,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0455.883.073
- Incorporation
- 31/08/1995
- Legal form
- Public limited company
- Registered office
- Leonardo da Vincilaan 15
1831 Machelen (Brab.) · FlandreSee on map - Contributed capital
- 443 256,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,0 ETP
Activities (NACE)
Joint committees (3)
- 100
- 200
- 218
Signals
ProfitableGood liquidityPositive cashflowHealthy social debtsHigh revenue
Financials
Source · NBB, 22 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 107 M € | +6.5% | 100,4 M € | +16.3% | 86,3 M € | +4.6% | 82,5 M € | +61.6% | 51,1 M € |
| EBITDA | -1,1 M € | -222% | 910 k € | -66.7% | 2,7 M € | +25.7% | 2,2 M € | +34.6% | 1,6 M € |
| Operating result | -1,5 M € | -269% | 910 k € | -66.7% | 2,7 M € | +25.8% | 2,2 M € | +51.2% | 1,4 M € |
| Net result | 32 k € | +147% | 12,9 k € | -99.0% | 1,3 M € | -18.7% | 1,6 M € | +18.4% | 1,3 M € |
| Balance sheet | |||||||||
| Equity | 18,5 M € | +0.2% | 18,4 M € | +0.1% | 18,4 M € | +7.5% | 17,1 M € | +39.8% | 12,2 M € |
| Total assets | 66,5 M € | +38.0% | 48,2 M € | -1.0% | 48,7 M € | +27.9% | 38,1 M € | +52.1% | 25 M € |
| Cash | 107 k € | -5.4% | 113,1 k € | -0.6% | 113,8 k € | -0.5% | 114,3 k € | +13.3% | 100,9 k € |
| Debts | 47,2 M € | +58.4% | 29,8 M € | -1.7% | 30,3 M € | +44.6% | 21 M € | +63.8% | 12,8 M € |
| Other | |||||||||
| Workforce | 1,0 ETP | -23.1% | 1,3 ETP | 0.0% | 1,3 ETP | -35.0% | 2,0 ETP | -9.1% | 2,2 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active · 19 ended
Active mandates
Elena Gironi
ActiveWim Adriaenssens
ActiveEnded mandates
Elena Gironi
EndedWim Adriaenssen
EndedWim Adriaenssens
EndedWim Adriaenssens
EndedOther companies at this address
Leonardo da Vincilaan 15 1831 Machelen (Brab.)| Company | CBE no. |
|---|---|
| 0461.779.386 | |
DePuy Synthes (Belgium)● Active | 1038.037.976 |
GMED HEALTHCARE● Active | 0822.358.674 |
JJSV Belgium● Active | 0477.259.497 |
| 1038.504.467 | |
JOHNSON & JOHNSON MEDICAL● Active | 0425.967.580 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/07/2026 | 11/07/2025 | 05/07/2024 | 10/07/2023 | 27/06/2022 | 16/11/2021 |
| General meeting | 29/06/2026 | 25/06/2025 | 17/06/2024 | 30/06/2023 | 24/06/2022 | 03/09/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 22 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/06/2026 | 06/07/2026 | Dutch | |
| Full model | 31/12/2024 | 25/06/2025 | 11/07/2025 | Dutch | |
| Full model | 31/12/2023 | 17/06/2024 | 05/07/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 10/07/2023 | Dutch | |
| Full model | 31/12/2021 | 24/06/2022 | 27/06/2022 | Dutch | |
| Full modelCorrection | 31/12/2020 | 03/09/2021 | 16/11/2021 | Dutch | |
| Full model | 31/12/2020 | 03/09/2021 | 07/09/2021 | Dutch | |
| Full modelCorrection | 31/12/2019 | 11/06/2021 | 16/11/2021 | Dutch | |
| Full model | 31/12/2019 | 11/06/2021 | 09/07/2021 | Dutch | |
| Full model | 31/12/2018 | 24/06/2019 | 28/06/2019 | Dutch | |
| Full model | 31/12/2017 | 28/06/2018 | 02/07/2018 | Dutch | |
| Full model | 31/12/2016 | 30/06/2017 | 08/08/2017 | Dutch | |
| Full model | 31/12/2015 | 30/06/2016 | 22/08/2016 | Dutch | |
| Full model | 31/12/2014 | 04/09/2015 | 14/09/2015 | Dutch | |
| Full model | 31/12/2013 | 30/06/2014 | 23/07/2014 | Dutch | |
| Full model | 31/12/2012 | 11/10/2013 | 08/11/2013 | Dutch | |
| Full model | 31/12/2011 | 07/01/2013 | 01/03/2013 | Dutch | |
| Full model | 31/12/2010 | 12/12/2011 | 23/01/2012 | Dutch | |
| Full model | 31/12/2009 | 03/11/2010 | 24/11/2010 | French | |
| Full model | 31/12/2008 | 15/10/2009 | 28/10/2009 | French | |
| Full model | 31/12/2007 | 17/06/2008 | 09/07/2008 | French | |
| Full model | 31/12/2006 | 19/06/2007 | 05/07/2007 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 19 ended
Active mandates
Elena Gironi
ActiveWim Adriaenssens
ActiveEnded mandates
Elena Gironi
EndedWim Adriaenssen
EndedWim Adriaenssens
EndedWim Adriaenssens
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates30/07/2024ONTSLAGEN - BENOEMINGEN
- Mandates06/09/2023ONTSLAGEN - BENOEMINGEN
- Mandates19/07/2023ONTSLAGEN - BENOEMINGEN
- Mandates22/07/2022ONTSLAGEN - BENOEMINGEN
- Mandates20/09/2021ONTSLAGEN - BENOEMINGEN
- Mandates06/03/2020ONTSLAGEN - BENOEMINGEN
- Other30/12/2019ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates26/09/2019ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202532 k €↑
- 2024Annual accounts 202412,9 k €↓
- 2023Annual accounts 20231,3 M €↓
- 2022Annual accounts 20221,6 M €↑
- 2018Annual accounts 20181,3 M €↓
- 2017Annual accounts 20172,1 M €↑
- 2016Annual accounts 2016268,7 k €↑
- 2015Annual accounts 201569,6 k €↑
- 2013Annual accounts 20138,6 k €↓
- 2010Annual accounts 20101,5 M €↓
- 2009Annual accounts 2009237,3 M €↑
- 2008Annual accounts 2008-16,6 k €↓
- 2007Annual accounts 20073 M €↓
- 2006Annual accounts 20065,9 M €
- 31/08/1995IncorporationPublic limited company